Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 72Neoplasms 46Squamous Cell Carcinoma of Head and Neck 45Head and Neck Neoplasms 35Lung Neoplasms 34Uterine Cervical Neoplasms 27Neoplasm Metastasis 25Unspecified Adult Solid Tumor, Protocol Specific 24Stomach Neoplasms 24Ovarian Neoplasms 24Small Cell Lung Carcinoma 20Pancreatic Neoplasms 18Colorectal Neoplasms 18Carcinoma, Squamous Cell 17Esophageal Neoplasms 16Cholangiocarcinoma 16Breast Neoplasms 15Mesothelioma, Malignant 14Melanoma 13Urinary Bladder Neoplasms 12Mesothelioma 11Fallopian Tube Neoplasms 11Carcinoma, Ovarian Epithelial 11Sarcoma 9Gallbladder Neoplasms 9Esophageal Squamous Cell Carcinoma 9Biliary Tract Neoplasms 9Carcinoma 8Recurrence 7Peritoneal Neoplasms 7

Interventions

angiotensin I (1-7) 1Traumeel S 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Melphalan 1Fibroblast Growth Factor 7 1Drug Therapy 1Cisplatin 1CBLB502 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Mucositis × Cisplatin × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡